ImmuCell Corporation Increase (Decrease) in Receivables
ImmuCell Corporation (ICCC) reported Increase (Decrease) in Receivables of -$358.81 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2018-08-13
- ImmuCell Corporation increase (decrease) in receivables for the quarter ending 2018-06-30 was -$14.68K.
- ImmuCell Corporation increase (decrease) in receivables for the quarter ending 2018-03-31 was -$344.12K, a 1790.86% decline year-over-year.
- ImmuCell Corporation increase (decrease) in receivables for the quarter ending 2017-12-31 was $471.42K, a 49.07% increase year-over-year.
- ImmuCell Corporation increase (decrease) in receivables for the quarter ending 2017-09-30 was $163.67K.
- ImmuCell Corporation increase (decrease) in receivables for fiscal 2017 was $330.31K, a 19.02% increase from fiscal 2016.
- ImmuCell Corporation increase (decrease) in receivables for fiscal 2016 was $277.52K.
- ImmuCell Corporation increase (decrease) in receivables for fiscal 2015 was -$249.29K, a 166.68% decline from fiscal 2014.
- ImmuCell Corporation increase (decrease) in receivables for fiscal 2014 was $373.88K, a 1764.19% increase from fiscal 2013.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 3 month as first filed | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 6 month as first filed | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 9 month as first filed | Increase (Decrease) in Receivables 12 month | Increase (Decrease) in Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | -$14.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$358.81K 10-Q · filed 2018-08-13 | $112.61K derived: sum of 3 quarters · filed 2018-08-13 | $276.28K derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2018-03-31 | -$344.12K 10-Q · filed 2018-05-14 | $127.30K derived: sum of 2 quarters · filed 2018-05-14 | $290.97K derived: sum of 3 quarters · filed 2018-05-14 | -$34.17K derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-12-31 | $471.42K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $635.09K derived: sum of 2 quarters · filed 2018-03-29 | $309.95K derived: sum of 3 quarters · filed 2018-08-13 | $330.31K 10-K · filed 2018-03-29 | ||||
| 2017-09-30 | $163.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$161.47K derived: sum of 2 quarters · filed 2018-08-13 | -$141.11K 10-Q · filed 2017-11-13 | $175.13K derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-06-30 | -$325.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$304.78K 10-Q · filed 2018-08-13 | $11.46K derived: sum of 3 quarters · filed 2018-08-13 | -$258.00K derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | $20.35K 10-Q · filed 2018-05-14 | $336.60K derived: sum of 2 quarters · filed 2018-05-14 | $67.13K derived: sum of 3 quarters · filed 2018-05-14 | -$404.44K derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | $316.24K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $46.78K derived: sum of 2 quarters · filed 2018-03-29 | -$424.79K derived: sum of 3 quarters · filed 2018-03-29 | $277.52K 10-K · filed 2018-03-29 | ||||
| 2016-09-30 | -$269.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$741.04K derived: sum of 2 quarters · filed 2017-11-13 | -$38.72K 10-Q · filed 2017-11-13 | -$73.83K derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | -$471.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $230.74K 10-Q · filed 2017-08-14 | $229.19K 10-Q · filed 2016-08-11 | $195.63K derived: sum of 3 quarters · filed 2017-08-14 | $253.52K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | $702.32K 10-Q · filed 2017-05-11 | $701.75K 10-Q · filed 2016-05-11 | $667.21K derived: sum of 2 quarters · filed 2017-05-11 | $725.10K derived: sum of 3 quarters · filed 2017-05-11 | $703.46K derived: sum of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | -$35.11K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $22.78K derived: sum of 2 quarters · filed 2017-03-30 | $1.15K derived: sum of 3 quarters · filed 2017-03-30 | -$249.29K 10-K · filed 2017-03-30 | -$251.19K 10-K · filed 2016-03-25 | |||
| 2015-09-30 | $57.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $36.26K derived: sum of 2 quarters · filed 2016-11-10 | -$214.18K 10-Q · filed 2016-11-10 | -$216.08K 10-Q · filed 2015-11-12 | $227.55K derived: sum of 4 quarters · filed 2016-11-10 | |||
| 2015-06-30 | -$21.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$272.07K 10-Q · filed 2016-08-11 | -$270.33K 10-Q · filed 2015-08-13 | $169.66K derived: sum of 3 quarters · filed 2016-08-11 | $304.79K derived: sum of 4 quarters · filed 2016-08-11 | |||
| 2015-03-31 | -$250.44K 10-Q · filed 2016-05-11 | $191.29K derived: sum of 2 quarters · filed 2016-05-11 | $326.43K derived: sum of 3 quarters · filed 2016-05-11 | $34.83K derived: sum of 4 quarters · filed 2016-05-11 | ||||
| 2014-12-31 | $441.73K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $576.87K derived: sum of 2 quarters · filed 2016-03-25 | $285.27K derived: sum of 3 quarters · filed 2016-03-25 | $373.88K 10-K · filed 2016-03-25 | ||||
| 2014-09-30 | $135.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$156.46K derived: sum of 2 quarters · filed 2015-11-12 | -$67.85K 10-Q · filed 2015-11-12 | $160.26K derived: sum of 4 quarters · filed 2016-03-25 | ||||
| 2014-06-30 | -$291.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$202.98K 10-Q · filed 2015-08-13 | $25.12K derived: sum of 3 quarters · filed 2016-03-25 | -$129.26K derived: sum of 4 quarters · filed 2016-03-25 | ||||
| 2014-03-31 | $88.62K 10-Q · filed 2015-05-12 | $316.72K derived: sum of 2 quarters · filed 2016-03-25 | $162.34K derived: sum of 3 quarters · filed 2016-03-25 | $7.13K derived: sum of 4 quarters · filed 2016-03-25 | ||||
| 2013-12-31 | $228.11K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $73.73K derived: sum of 2 quarters · filed 2016-03-25 | -$81.48K derived: sum of 3 quarters · filed 2016-03-25 | $20.06K 10-K · filed 2016-03-25 | ||||
| 2013-09-30 | -$154.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$309.59K derived: sum of 2 quarters · filed 2014-11-12 | -$208.05K 10-Q · filed 2014-11-12 | |||||
| 2013-06-30 | -$155.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$53.67K 10-Q · filed 2014-08-13 | ||||||
| 2013-03-31 | $101.54K 10-Q · filed 2014-05-14 | |||||||
| 2012-12-31 | $227.56K 10-K · filed 2015-03-26 | |||||||
| 2011-12-31 | -$113.72K 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |